Hutch News

Hutch News

Stories tagged 'remission'

Replenishing immune cells after remission

New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy

Oct. 17, 2016 | By Bill Briggs / Fred Hutch News Service

Scientists at Fred Hutch, Seattle Children’s Research Institute, and Technical University of Munich showed that activating a “kill switch” can turn off CAR T cells after doctors deem a cancer defeated, allowing normal B cells to again flourish.

View story >


Investigational immunotherapy halts advanced melanoma

Cassian Yee study shows progress in using patients' own tumor-fighting cells to knock back late-stage skin cancer

March 5, 2012 | By Dean Forbes

A small, early-phase clinical trial, led by Dr. Cassian Yee of the Hutchinson Center's Clinical Research Division, to test the effectiveness of treating patients with advanced melanoma using billions of clones of their own tumor-fighting cells combined with a specific type of chemotherapy has shown that the approach has promise. One patient of the 11 experienced a long-term, complete remission that has lasted more than three years, and in four others with progressive disease, the melanoma temporarily stopped growing. The results of the study appear in the March 5 early edition of the Proceedings of the National Academy of Sciences.

View story >


Patient's cloned T cells kill tumors

Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission

June 23, 2008 | By Dean Forbes

Scientists from Fred Hutchinson Cancer Research Center describe the first successful use of a human patient’s cloned infection-fighting T-cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.